DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Nausea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Nausea (195)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 195   Next >>

Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Myalgia, Injection Site Haemorrhage, Nausea, Chills, Sinus Headache, Hyperhidrosis, Muscle Spasms

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Haemoglobin Decreased, Dysgeusia, Nausea, Chills, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw

Rebetol
    Dosage: unk
    Administration route: Oral

Victrelis
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Protonix



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Fatigue, Nausea, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw

Rebetol
    Administration route: Oral

Other drugs received by patient: Zyrtec; Lisinopril; Nortriptyline HCL; Atenolol; Prilosec; Estradiol



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-25

Patient:

Reactions: Nausea, Flatulence

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-27



Possible PEG-Intron side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 54 year old female

Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-28

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-06-12

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-19

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-20
    End date: 2012-07-31

VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-21

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-05-08

Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: Myalgia, Diarrhoea, Nausea, Chills

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Ribavirin



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-11

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-05-31

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-01

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-07-06

Other drugs received by patient: Loxonin; Antebate



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: Abdominal Pain, Oral Mucosal Blistering, Vomiting, LIP Blister, Nausea, Muscle Spasms

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Start date: 2012-08-17
    End date: 2012-08-19

Rebetol



Possible PEG-Intron side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 67 year old female

Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.94 a?g/kg, unk
    Start date: 2012-04-06
    End date: 2012-04-26

PEG-Intron
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-03-30

PEG-Intron
    Dosage: 1.13 a?g/kg, unk
    Start date: 2012-04-27
    End date: 2012-05-10

PEG-Intron
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-05-11
    End date: 2012-08-02

PEG-Intron
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-03-29

PEG-Intron
    Start date: 2012-05-11

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-16
    End date: 2012-04-19

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-08-02

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-02-23

VX-950
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-03-23
    End date: 2012-04-13

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-22

VX-950
    Dosage: 2250 mg, qd
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-02-23

Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient:

Reactions: Fatigue, Sleep Disorder, Nausea, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-07-19

Ribasphere
    Dosage: unk
    Start date: 2012-07-19

Victrelis
    Dosage: 800 mg/tid
    Administration route: Oral
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible PEG-Intron side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Nausea, Product Taste Abnormal

Drug(s) suspected as cause:
PEG-Intron

Rebetol
    Dosage: unk
    Administration route: Oral

Victrelis
    Dosage: 4 df, tid
    Administration route: Oral
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Nausea, RED Blood Cell Count Decreased, Asthenia, Somnolence

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-23

Rebetol
    Dosage: 200 mg, bid
    Administration route: Oral

Rebetol
    Dosage: 400 mg,
    Indication: Hepatitis C
    Start date: 2012-02-23

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-03-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-09-08
    End date: 2012-08-09

Ribavirin
    Dosage: unk unk, unknown
    Start date: 2011-09-08
    End date: 2012-08-09

Other drugs received by patient: Telaprevir



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-04-13

PEG-Intron
    Dosage: 0.4 ml, unk

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Nausea, Decreased Appetite

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-03-29

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-16

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-16

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-16

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-03-29

Telavic
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-16

Other drugs received by patient: Levocarnitine Hydrochloride; Rabeprazole Sodium; Primperan TAB; L Cartin; Rebamipide



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Nausea, Erythema, Neutrophil Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-02-24

Rebetol
    Dosage: 800 mg, qd,cumulative dose:3200 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-06-03

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Antebate; Loxonin; Valsartan; Lasix; Amino Acids (Unspecified); Norvasc; Lansoprazole; Allegra; Petrolatum; Aspirin; Humalog; Doxazosin Mesylate



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Nausea, Pyrexia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Start date: 2012-07-01

Ribasphere

Ribavirin



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, General Physical Health Deterioration, Dizziness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Nesina; Metformin HCL; Adalat CC; Doxazosin Mesylate; Amaryl; Amaryl; Kinedak; Allopurinol; Olmesartan Medoxomil; Trichlormethiazide; Loxonin; Primperan TAB; Adalat CC; Olmesartan Medoxomil; Vitamin B12; Loxonin; Doxazosin Mesylate; Kinedak; Loxonin; Loxonin; Potassium Chloride; Lyrica; Lendormin D; Adalat CC; Metformin HCL; Lendormin; Rohypnol; Electrolytes (Unspecified) (+) Sodium Lactate; Glycyron; Trichlormethiazide; Nesina; Urso 250; Vitamin E; Adalat CC



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Contusion, Head Discomfort, Somnolence, Fall, Abdominal Pain Upper, Loss of Consciousness, Fatigue, Dizziness, Blood Creatinine Increased, Migraine, Back Pain, Nausea, Hypotension, Convulsion, Eye Pain, Tremor

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-09

Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
Incivek
    Dosage: 2 df, q8h
    Administration route: Oral

PEG-Intron

Rebetol
    Administration route: Oral

Other drugs received by patient: Lorazepam; Ferrous Sulfate TAB; Levothyroxine Sodium; Tylenol



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-22

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-02-29

PEG-Intron
    Dosage: 0mcg/kg

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-14

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-03-07

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-07

Telavic
    Administration route: Oral

Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-21

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-17

Rebetol
    Administration route: Oral
    Start date: 2012-06-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-24

Telavic
    Administration route: Oral
    Start date: 2012-06-25

Other drugs received by patient: Voltaren; Mucosta



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-22

Patient:

Reactions: Vomiting, Renal Disorder, Nausea

Drug(s) suspected as cause:
Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Investigational Drug (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-04-03

Investigational Drug (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-04-04

PEG-Intron
    Dosage: 1.3mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-28

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-02-24
    End date: 2012-02-24

Peginterferon Alfa-2B
    Dosage: 80 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-23

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Rebetol
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-02-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Telavic
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-02-26

Telavic
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-04-03

Telavic
    Administration route: Oral
    Start date: 2012-04-04

Telavic
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Other drugs received by patient: Warfarin Sodium; Urso 250; Digoxin; Urso 250; Nizatidine; Efonidipine Hydrochloride Ethanolate; Nizatidine; Diovan



Possible PEG-Intron side effects in

Reported by a pharmacist from United States on 2012-08-22

Patient:

Reactions: Confusional State, Dyspnoea, Nausea, Anaemia, Rectal Haemorrhage, DRY Skin, Amnesia, Fatigue, Diarrhoea, DRY Mouth, Alopecia, Anorectal Discomfort, Depressed Mood, Injection Site Exfoliation, Aphonia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qw, per injection

Rebetol
    Dosage: unk

Other drugs received by patient: Tricor; Micardis; Omega-3-Acid Ethyl Esters; Wellbutrin; Cardura; Vitamin E; Glucosamine



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Nausea, Brain Abscess, Blood Uric Acid Increased, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-24

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16
    End date: 2012-02-23

PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-16

PEG-Intron
    Dosage: 80 mcg/week
    Start date: 2012-01-16
    End date: 2012-05-07

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-03-08

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-04-16
    End date: 2012-04-22

Rebetol
    Dosage: 200 mg/2 days
    Administration route: Oral
    Start date: 2012-03-09
    End date: 2012-04-14

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-01-16
    End date: 2012-02-26

Rebetol
    Dosage: 400 mg/2 days
    Administration route: Oral
    Start date: 2012-03-10
    End date: 2012-04-15

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-13

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16
    End date: 2012-02-23

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-04-09

Other drugs received by patient: Carvedilol; Allegra; Carvedilol; Allegra; Diovan; Diovan; Naqua; [therapy Unspecified]; Trichlormethiazide



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-04

PEG-Intron
    Dosage: 1mcg/kg/week
    Start date: 2012-06-11
    End date: 2012-06-18

PEG-Intron
    Dosage: 0.8mcg/kg/week
    Start date: 2012-06-25

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-10

Rebetol
    Administration route: Oral
    Start date: 2012-06-11

Telavic
    Administration route: Oral
    Start date: 2012-07-02

Telavic
    Administration route: Oral
    Start date: 2012-06-11
    End date: 2012-07-01

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-10



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014